Definitive Contract 75A50120C00102

Award Date 4/28/20
Potential Completion Date 3/15/22
Potential Value $20M
Ultimate Awardee
Abbott Laboratories
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lockhart, FL 32810, USA
Solicitation Procedures
Only One Source
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $11.9 million firm fixed price definitive contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to purchase ID NOWTM COVID-19 rapid testing kits. The contract supports HHS/ASPR's requirement to obtain coronavirus testing capabilities in response to the COVID-19 pandemic. Performance will take place in Lockhart, Florida through July 2022. No...
The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response awarded a $174.4 million firm fixed price definitive contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to purchase ID NOWTM COVID-19 rapid testing kits. The contract supports ASPR's requirement to obtain coronavirus testing supplies in support of the federal government's COVID-19 response efforts. Performance will take place in Chamblee, Georgia through...
This is a $257,060,695.20 firm-fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency, to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, for the procurement of over-the-counter (OTC) COVID-19 tests. The contract has a completion date of March 30, 2023 and does not utilize a set-aside designation. Abbott Rapid DX North America LLC is a major supplier of COVID-19 diagnostic products,...
The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $6.6 million firm fixed price delivery order to supply 850,773 units of Abbott's BinaxNOW COVID-19 antigen test cards. Performance will take place in Lockhart, Florida through October 27, 2020. This order was placed under the National Interest Action Code for coronavirus response to support the Department of Defense's COVID-19 testing efforts. No subcontractors...
This federal contract award, valued at $4,020.20, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of BinaxNOW COVID-19 antigen test cards, a critical diagnostic product supporting the U.S. government's pandemic response efforts. The contract is a fixed-price with economic price adjustment and does not have a set-aside designation. Abbott Rapid DX North America LLC is...
The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $20.4 million firm fixed price delivery order to supply 850,000 Abbott BinaxNOW COVID-19 antigen test cards. The tests will support the Department of Defense's coronavirus response efforts. Performance will occur at Abbott's Lockhart, Florida facility by December 30, 2020. No set aside provisions or subcontractors were identified. The delivery order was issued...
The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $15.3 million firm fixed price delivery order to supply 8507785418 BINAXNOW COVID-19 antigen cards. Under this contract, Abbott will deliver approximately 375,000 COVID-19 rapid test kits to a location in Lockhart, Florida by November 18, 2020 to support the Department of Defense's response to the coronavirus pandemic. The tests will be provided off Abbott's GSA...
The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $21.4 million firm fixed price delivery order to supply 8507767382 BINAXNOW COVID-19 antigen test cards. Under this contract, Abbott will deliver approximately 500,000 test cards to a location in Lockhart, Florida by November 9, 2020 to support the Department of Defense's medical response efforts to the coronavirus pandemic. As a leading provider of point-of-care...
This federal contract award (SPE2DE20D0027|SPE2DE21F0144) was made by the Defense Logistics Agency (DLA) Troop Support Medical to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories. The contract is for the delivery of BinaxNOW COVID-19 Ag Card testing kits, with a ceiling value of $46,952,571.50. This Delivery Order contract is Firm Fixed Price and does not have a set-aside designation. The contract supports the National Interest Action Code for the Coronavirus COVID-19...
The Defense Logistics Agency Troop Support Medical awarded Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, a $10.2 million delivery order to supply 850,777 units of Abbott's BinaxNOW COVID-19 antigen test cards. The tests will be delivered to a location in Lockhart, Florida by November 10, 2020 to support the Department of Defense's response to the coronavirus pandemic. Abbott will provide the tests as the prime contractor under the delivery order, which was awarded on an...

The Department of Health and Human Services' Office of the Assistant Secretary for Preparedness and Response (HHS ASPR) awarded a $19.7 million firm fixed price definitive contract to Abbott Rapid DX North America LLC, a subsidiary of Abbott Laboratories, to purchase ID NOWTM COVID-19 rapid testing kits. The contract supports HHS ASPR's requirement to obtain coronavirus testing capabilities in response to the COVID-19 pandemic. Performance will take place in Lockhart, Florida through March 2022. No set aside provisions or subcontracting arrangements were identified. This definitive contract under the HHS ASPR allows the agency to secure Abbott's point-of-care molecular diagnostic tests as it works to expand the nation's COVID-19 testing capacity during the public health emergency.

Generated 12/25/23, 3:06 AM